QUEBEC, Feb. 5, 2025 /PRNewswire/ – Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major scientific breakthrough, diaMentis unveils unprecedented results for the optimization and acceleration of mental illness diagnosis,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.